首页 > 最新文献

Lancet Infectious Diseases最新文献

英文 中文
COVID-19 versus influenza: the need to align policies with COVID-19 realities
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00001-5
Yan Xie
No Abstract
{"title":"COVID-19 versus influenza: the need to align policies with COVID-19 realities","authors":"Yan Xie","doi":"10.1016/s1473-3099(25)00001-5","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00001-5","url":null,"abstract":"No Abstract","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"39 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research in brief
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00029-5
Priya Venkatesan
<h2>Section snippets</h2><section><section><h2>Bedaquiline monotherapy for leprosy</h2>Monotherapy with bedaquiline, a diarylquinoline used to treat pulmonary multidrug-resistant tuberculosis, is efficacious in patients with multibacillary leprosy, suggests a phase 2, open-label <span><span>study</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> in Brazil. Nine adult patients with previously untreated leprosy consisting of at least six skin lesions received oral bedaquiline 200 mg once daily for 2 weeks, followed by bedaquiline 100 mg three times per week for 6 weeks. After 8 weeks of bedaquiline, patients started standard multidrug therapy</section></section><section><section><h2>RSV vaccination in people who are immunocompromised</h2>A US prospective cohort <span><span>study</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> examined antibody responses to respiratory syncytial virus (RSV) vaccination in patients with immunocompromising conditions. 38 individuals (median age 66 years [IQR 64–72], 50% female) who were planning to receive adjuvanted RSVPreF3-AS01E or nonadjuvanted RSVpreF vaccinations provided blood samples before vaccination and at 2, 4, and 12 weeks after. Only 23 participants (61%) achieved seroconversion by week 4 post-vaccination, defined as a four-fold or greater</section></section><section><section><h2>Vaccine-strain rotavirus in a neonatal intensive care unit</h2>Rotavirus vaccines have reduced rotavirus-associated morbidity and mortality in children worldwide. However, many neonatal intensive care units (NICUs) in the USA do not administer the vaccine to hospitalised children (including preterm infants) due to a theoretical risk of transmission of vaccine strains to unvaccinated infants. A cohort <span><span>study</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> was undertaken over 1 year in a US NICU that routinely administered 226 doses of pentavalent rotavirus vaccine (RV5). Stool samples from only five of</section></section><section><section><h2>Translocation of Ebola virus to human skin surfaces</h2>Ebola virus is spread by direct contact with infected individuals and their bodily fluids, primarily via mucosal transmission. However, infectious virus is also present on the skin surfaces of infected individuals at later times during infection and after death, implicating skin contact as a source of transmission. To understand the mechanism behind skin translocation of the virus, <span><span>researchers</span><svg aria-label="Opens in new wind
{"title":"Research in brief","authors":"Priya Venkatesan","doi":"10.1016/s1473-3099(25)00029-5","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00029-5","url":null,"abstract":"&lt;h2&gt;Section snippets&lt;/h2&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Bedaquiline monotherapy for leprosy&lt;/h2&gt;Monotherapy with bedaquiline, a diarylquinoline used to treat pulmonary multidrug-resistant tuberculosis, is efficacious in patients with multibacillary leprosy, suggests a phase 2, open-label &lt;span&gt;&lt;span&gt;study&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; in Brazil. Nine adult patients with previously untreated leprosy consisting of at least six skin lesions received oral bedaquiline 200 mg once daily for 2 weeks, followed by bedaquiline 100 mg three times per week for 6 weeks. After 8 weeks of bedaquiline, patients started standard multidrug therapy&lt;/section&gt;&lt;/section&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;RSV vaccination in people who are immunocompromised&lt;/h2&gt;A US prospective cohort &lt;span&gt;&lt;span&gt;study&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; examined antibody responses to respiratory syncytial virus (RSV) vaccination in patients with immunocompromising conditions. 38 individuals (median age 66 years [IQR 64–72], 50% female) who were planning to receive adjuvanted RSVPreF3-AS01E or nonadjuvanted RSVpreF vaccinations provided blood samples before vaccination and at 2, 4, and 12 weeks after. Only 23 participants (61%) achieved seroconversion by week 4 post-vaccination, defined as a four-fold or greater&lt;/section&gt;&lt;/section&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Vaccine-strain rotavirus in a neonatal intensive care unit&lt;/h2&gt;Rotavirus vaccines have reduced rotavirus-associated morbidity and mortality in children worldwide. However, many neonatal intensive care units (NICUs) in the USA do not administer the vaccine to hospitalised children (including preterm infants) due to a theoretical risk of transmission of vaccine strains to unvaccinated infants. A cohort &lt;span&gt;&lt;span&gt;study&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; was undertaken over 1 year in a US NICU that routinely administered 226 doses of pentavalent rotavirus vaccine (RV5). Stool samples from only five of&lt;/section&gt;&lt;/section&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Translocation of Ebola virus to human skin surfaces&lt;/h2&gt;Ebola virus is spread by direct contact with infected individuals and their bodily fluids, primarily via mucosal transmission. However, infectious virus is also present on the skin surfaces of infected individuals at later times during infection and after death, implicating skin contact as a source of transmission. To understand the mechanism behind skin translocation of the virus, &lt;span&gt;&lt;span&gt;researchers&lt;/span&gt;&lt;svg aria-label=\"Opens in new wind","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"28 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adriaan Willem Sturm
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00021-0
Sanjeet Bagcchi
  1. Download: Download high-res image (52KB)
  2. Download: Download full-size image
{"title":"Adriaan Willem Sturm","authors":"Sanjeet Bagcchi","doi":"10.1016/s1473-3099(25)00021-0","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00021-0","url":null,"abstract":"<span><figure><span><img alt=\"\" height=\"173\" src=\"https://ars.els-cdn.com/content/image/1-s2.0-S1473309925000210-fx1.jpg\"/><ol><li><span><span>Download: <span>Download high-res image (52KB)</span></span></span></li><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span></figure></span>","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"49 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143056974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal views on RSV vaccination during the first season of implementation in England and Scotland
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00060-x
Thomas C Williams, Robin Marlow, Steve Cunningham, Simon B Drysdale, Helen Groves, Dalia Iskander, Xinxue Liu, Mark D Lyttle, Chengetai D Mpamhanga, Shaun O'Hagan, Thomas Waterfield, Damian Roland
No Abstract
{"title":"Maternal views on RSV vaccination during the first season of implementation in England and Scotland","authors":"Thomas C Williams, Robin Marlow, Steve Cunningham, Simon B Drysdale, Helen Groves, Dalia Iskander, Xinxue Liu, Mark D Lyttle, Chengetai D Mpamhanga, Shaun O'Hagan, Thomas Waterfield, Damian Roland","doi":"10.1016/s1473-3099(25)00060-x","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00060-x","url":null,"abstract":"No Abstract","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"53 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHO reports gaps in global IPC programmes
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00026-x
Timothy Jesudason
No Abstract
{"title":"WHO reports gaps in global IPC programmes","authors":"Timothy Jesudason","doi":"10.1016/s1473-3099(25)00026-x","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00026-x","url":null,"abstract":"No Abstract","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"20 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jimmy Carter—a legacy
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00025-8
Talha Burki
No Abstract
{"title":"Jimmy Carter—a legacy","authors":"Talha Burki","doi":"10.1016/s1473-3099(25)00025-8","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00025-8","url":null,"abstract":"No Abstract","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"79 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infectious disease surveillance update
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00023-4
Cahal McQuillan
<h2>Section snippets</h2><section><section><h2>Hepatitis A in Slovakia</h2>On Dec 19, 2024, the Regional Public Health Office (RUVZ) in Bratislava, Slovakia, <span><span>reported</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> an increase in the number of hepatitis A cases in all districts of the Bratislava region. According to the RUVZ, 73 cases of hepatitis A were recorded between Jan 1 and Dec 19, 2024, with 24 cases recorded in Dec 1–19 alone. The RUVZ state that vaccination is the most effective method of prevention, and, at this time, they are also emphasising personal hygiene, such as handwashing, as a preventive</section></section><section><section><h2>Japanese encephalitis in Australia</h2>On Dec 31, 2024, Victoria's Department of Health <span><span>reported</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> a probable human case of Japanese encephalitis in a northern area of the Australian state. The first-ever case of Japanese encephalitis in Victoria was reported in 2022, and this is the first recorded case since that mosquito season. Through environmental surveillance, the virus has been detected in mosquitoes and feral pigs, which authorities say indicates that it is circulating in Victoria this summer. The Department of Health</section></section><section><section><h2>Measles in Pakistan</h2>On Dec 31, 2024, it was <span><span>reported</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> that measles cases were on the rise again in Sindh province in Pakistan following a substantial drop in infections over the previous few months. This comes after the country saw its highest number of cases in decades in 2024. The health department's data show that there were more than 13 000 suspected cases, 6670 confirmed cases, and 132 child deaths related to measles last year. Despite the availability of a free and effective vaccine, 350 suspected and 155</section></section><section><section><h2>Gastroenteritis in Brazil</h2>On Jan 5, 2025, the State Department of Health of São Paulo <span><span>reported</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span> an outbreak of gastroenteritis in Guarujá and a possible outbreak in Playa Grande. The full extent of the outbreak is unknown, but it has been reported that there were almost 2000 cases in Guarujá in December, 2024. It is suspected that infections resulted from co
{"title":"Infectious disease surveillance update","authors":"Cahal McQuillan","doi":"10.1016/s1473-3099(25)00023-4","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00023-4","url":null,"abstract":"&lt;h2&gt;Section snippets&lt;/h2&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Hepatitis A in Slovakia&lt;/h2&gt;On Dec 19, 2024, the Regional Public Health Office (RUVZ) in Bratislava, Slovakia, &lt;span&gt;&lt;span&gt;reported&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; an increase in the number of hepatitis A cases in all districts of the Bratislava region. According to the RUVZ, 73 cases of hepatitis A were recorded between Jan 1 and Dec 19, 2024, with 24 cases recorded in Dec 1–19 alone. The RUVZ state that vaccination is the most effective method of prevention, and, at this time, they are also emphasising personal hygiene, such as handwashing, as a preventive&lt;/section&gt;&lt;/section&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Japanese encephalitis in Australia&lt;/h2&gt;On Dec 31, 2024, Victoria's Department of Health &lt;span&gt;&lt;span&gt;reported&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; a probable human case of Japanese encephalitis in a northern area of the Australian state. The first-ever case of Japanese encephalitis in Victoria was reported in 2022, and this is the first recorded case since that mosquito season. Through environmental surveillance, the virus has been detected in mosquitoes and feral pigs, which authorities say indicates that it is circulating in Victoria this summer. The Department of Health&lt;/section&gt;&lt;/section&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Measles in Pakistan&lt;/h2&gt;On Dec 31, 2024, it was &lt;span&gt;&lt;span&gt;reported&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; that measles cases were on the rise again in Sindh province in Pakistan following a substantial drop in infections over the previous few months. This comes after the country saw its highest number of cases in decades in 2024. The health department's data show that there were more than 13 000 suspected cases, 6670 confirmed cases, and 132 child deaths related to measles last year. Despite the availability of a free and effective vaccine, 350 suspected and 155&lt;/section&gt;&lt;/section&gt;&lt;section&gt;&lt;section&gt;&lt;h2&gt;Gastroenteritis in Brazil&lt;/h2&gt;On Jan 5, 2025, the State Department of Health of São Paulo &lt;span&gt;&lt;span&gt;reported&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; an outbreak of gastroenteritis in Guarujá and a possible outbreak in Playa Grande. The full extent of the outbreak is unknown, but it has been reported that there were almost 2000 cases in Guarujá in December, 2024. It is suspected that infections resulted from co","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"22 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid abscess caused by mucormycosis in a child with acute lymphoblastic leukaemia
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(24)00753-9
Xu Yang, Yufeng Liang, Huiying Wu, Xiaohong Zhang

Section snippets

Contributors

XY: conceptualisation, investigation, project administration, validation, visualisation, writing of the original draft, and review and editing. YL and HW: investigation, resources, validation, and review and editing. XZ: conceptualisation, investigation, methodology, project administration, resources, validation, supervision, review and editing. All authors had full access to the data and had final responsibility for the decision to submit for publication. Informed written consent for the

Declaration of interests

We declare no competing interests.

Acknowledgments

This work was supported by the Guangzhou Municipal Science and Technology Project (2024A03J1240).
{"title":"Thyroid abscess caused by mucormycosis in a child with acute lymphoblastic leukaemia","authors":"Xu Yang, Yufeng Liang, Huiying Wu, Xiaohong Zhang","doi":"10.1016/s1473-3099(24)00753-9","DOIUrl":"https://doi.org/10.1016/s1473-3099(24)00753-9","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Contributors</h2>XY: conceptualisation, investigation, project administration, validation, visualisation, writing of the original draft, and review and editing. YL and HW: investigation, resources, validation, and review and editing. XZ: conceptualisation, investigation, methodology, project administration, resources, validation, supervision, review and editing. All authors had full access to the data and had final responsibility for the decision to submit for publication. Informed written consent for the</section></section><section><section><h2>Declaration of interests</h2>We declare no competing interests.</section></section><section><section><h2>Acknowledgments</h2>This work was supported by the Guangzhou Municipal Science and Technology Project (2024A03J1240).</section></section>","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"60 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(24)00806-5
Peter Bager, Ingrid Bech Svalgaard, Frederikke Kristensen Lomholt, Hanne-Dorthe Emborg, Lasse Engbo Christiansen, Bolette Soborg, Anders Hviid, Lasse S Vestergaard

Background

The COVID-19 pandemic has been on a downward trend since May, 2022, but it continues to cause substantial numbers of hospital admissions and deaths. We describe this burden in the 2 years since May, 2022, and compare it with the burden of influenza in Denmark.

Methods

This observational cohort study included residents in Denmark from May 16, 2022, to June 7, 2024. Data were obtained from national registries, including admissions with COVID-19 or influenza (ie, having a positive PCR test for either virus from 14 days before and up to 2 days after the hospital admission date), deaths, sex, age, COVID-19 and influenza vaccination status, comorbidities, and residence in long-term care facilities. Negative binomial regression was used to estimate adjusted incidence rate ratios (aIRRs) to compare rates of hospital admissions between COVID-19 and influenza. To compare the severity of COVID-19 versus influenza among patients admitted to hospital, we used the Kaplan–Meier estimator to produce weighted cumulative incidence curves and adjusted risk ratios (aRRs) of mortality at 30 days between COVID-19 and influenza admissions.

Findings

Among 5 899 170 individuals, COVID-19 admissions (n=24 400) were more frequent than influenza admissions (n=8385; aIRR 2·04 [95% CI 1·38–3·02]), particularly during the first year (May, 2022, to May, 2023) versus the second year (May, 2023, to June, 2024; p=0·0096), in the summer versus the winter (p<0·0001), and among people aged 65 years or older versus younger than 65 years (p<0·0001). The number of deaths was also higher for patients with COVID-19 (n=2361) than patients with influenza (n=489, aIRR 3·19 [95% CI 2·24–4·53]). Among patients admitted in the winter (n=19 286), the risk of mortality from COVID-19 was higher than for influenza (aRR 1·23 [95% CI 1·08–1·37]), particularly among those without COVID-19 and influenza vaccination (1·36 [1·05–1·67]), with comorbidities (1·27 [1·11–1·43]), and who were male (1·36 [1·14–1·59]).

Interpretation

COVID-19 represented a greater disease burden than influenza, with more hospital admissions and deaths, and more severe disease (primarily among non-vaccinated people, those with comorbidities, and male patients). These results highlight the continued need for attention and public health efforts to mitigate the impact of SARS-CoV-2.

Funding

Danish Government.
{"title":"The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24","authors":"Peter Bager, Ingrid Bech Svalgaard, Frederikke Kristensen Lomholt, Hanne-Dorthe Emborg, Lasse Engbo Christiansen, Bolette Soborg, Anders Hviid, Lasse S Vestergaard","doi":"10.1016/s1473-3099(24)00806-5","DOIUrl":"https://doi.org/10.1016/s1473-3099(24)00806-5","url":null,"abstract":"<h3>Background</h3>The COVID-19 pandemic has been on a downward trend since May, 2022, but it continues to cause substantial numbers of hospital admissions and deaths. We describe this burden in the 2 years since May, 2022, and compare it with the burden of influenza in Denmark.<h3>Methods</h3>This observational cohort study included residents in Denmark from May 16, 2022, to June 7, 2024. Data were obtained from national registries, including admissions with COVID-19 or influenza (ie, having a positive PCR test for either virus from 14 days before and up to 2 days after the hospital admission date), deaths, sex, age, COVID-19 and influenza vaccination status, comorbidities, and residence in long-term care facilities. Negative binomial regression was used to estimate adjusted incidence rate ratios (aIRRs) to compare rates of hospital admissions between COVID-19 and influenza. To compare the severity of COVID-19 versus influenza among patients admitted to hospital, we used the Kaplan–Meier estimator to produce weighted cumulative incidence curves and adjusted risk ratios (aRRs) of mortality at 30 days between COVID-19 and influenza admissions.<h3>Findings</h3>Among 5 899 170 individuals, COVID-19 admissions (n=24 400) were more frequent than influenza admissions (n=8385; aIRR 2·04 [95% CI 1·38–3·02]), particularly during the first year (May, 2022, to May, 2023) versus the second year (May, 2023, to June, 2024; p=0·0096), in the summer versus the winter (p&lt;0·0001), and among people aged 65 years or older versus younger than 65 years (p&lt;0·0001). The number of deaths was also higher for patients with COVID-19 (n=2361) than patients with influenza (n=489, aIRR 3·19 [95% CI 2·24–4·53]). Among patients admitted in the winter (n=19 286), the risk of mortality from COVID-19 was higher than for influenza (aRR 1·23 [95% CI 1·08–1·37]), particularly among those without COVID-19 and influenza vaccination (1·36 [1·05–1·67]), with comorbidities (1·27 [1·11–1·43]), and who were male (1·36 [1·14–1·59]).<h3>Interpretation</h3>COVID-19 represented a greater disease burden than influenza, with more hospital admissions and deaths, and more severe disease (primarily among non-vaccinated people, those with comorbidities, and male patients). These results highlight the continued need for attention and public health efforts to mitigate the impact of SARS-CoV-2.<h3>Funding</h3>Danish Government.","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"10 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination in Africa—no hesitancy without access
IF 56.3 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-01-29 DOI: 10.1016/s1473-3099(25)00020-9
No Abstract
{"title":"Vaccination in Africa—no hesitancy without access","authors":"","doi":"10.1016/s1473-3099(25)00020-9","DOIUrl":"https://doi.org/10.1016/s1473-3099(25)00020-9","url":null,"abstract":"No Abstract","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"229 1","pages":""},"PeriodicalIF":56.3,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143056693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1